Pulse Biosciences Income Statement (2015-2025) | PLSE

Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
0.57M0.83M0.44M0.27M0.09M
Cost of Revenue (Quarter)
0.73M1.24M0.91M1.34M8.40M1.29M0.28M
Gross Profit (Quarter)
-0.15M-0.41M-0.47M-1.08M-8.40M-1.29M-0.19M
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)
9.06M7.46M6.46M5.66M6.77M5.46M4.52M4.09M5.83M6.70M7.47M7.80M6.74M7.23M7.70M10.66M10.31M12.09M11.39M
Selling, General & Administrative (Quarter)
5.32M4.20M4.26M5.30M4.50M3.79M3.09M2.58M3.73M3.53M3.78M4.73M3.87M4.50M5.95M9.60M7.73M8.19M8.78M
Other Operating Expenses (Quarter)
4.15M3.15M4.13M5.29M6.45M5.03M10.42M2.06M0.28M
Operating Expenses (Quarter)
18.52M14.81M14.85M16.25M17.72M14.28M18.02M8.74M9.56M10.23M11.25M12.53M10.62M11.73M13.65M20.26M18.04M20.27M20.45M
Operating Income (Quarter)
-18.52M-14.81M-14.27M-15.41M-17.27M-14.01M-18.02M-8.74M-9.56M-10.23M-11.25M-12.53M-10.62M-11.73M-13.65M-20.26M-18.04M-20.27M-20.37M
EBIT (Quarter)
-18.52M-14.81M-14.27M-15.41M-17.27M-14.01M-18.02M-8.74M-9.56M-10.23M-11.25M-12.53M-10.62M-11.73M-13.65M-20.26M-18.04M-20.27M-20.37M
Non-operating items
Interest & Investment Income (Quarter)
0.00M
Other Non Operating Income (Quarter)
-0.00M-0.02M
Non Operating Income (Quarter)
-0.11M-0.52M-0.01M-0.01M0.02M-0.01M-0.45M-0.24M0.32M0.69M0.60M0.48M0.34M0.97M0.87M1.25M1.11M1.00M
Net income details
EBT (Quarter)
-20.57M-20.31M-14.94M-15.46M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M87.80M-16.80M-19.17M-29.96M
Tax Provisions (Quarter)
Profit After Tax (Quarter)
-18.64M-15.32M-14.28M-15.42M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M-19.39M-16.80M-19.17M-19.39M
Income from Continuing Operations (Quarter)
-20.57M-20.31M-14.94M-15.46M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M87.80M-16.80M-19.17M-29.96M
Consolidated Net Income (Quarter)
-20.57M-20.31M-14.94M-15.46M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M87.80M-16.80M-19.17M-29.96M
Income towards Parent Company (Quarter)
-20.57M-20.31M-14.94M-15.46M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M87.80M-16.80M-19.17M-29.96M
Net Income towards Common Stockholders (Quarter)
-20.57M-20.31M-14.94M-15.46M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M87.80M-16.80M-19.17M-29.96M
Additional items
EPS (Basic) (Quarter)
-0.79-0.77-0.50-0.55-0.58-0.44-0.49-0.27-0.26-0.22-0.19-0.25-0.18-0.20-0.211.50-0.25-0.28-0.44
EPS (Diluted) (Quarter)
-0.77-0.50-0.52-0.58-0.44-0.49-0.25-0.26-0.27-0.28-0.32-0.27-0.31-0.342.36-0.45-0.52-0.81
Shares Outstanding (Quarter)
26.07M26.48M29.61M27.96M29.75M31.49M37.16M33.94M37.39M44.51M54.92M48.04M55.17M57.18M61.07M58.40M67.13M67.28M67.39M67.40M
Shares Outstanding (Diluted) (Quarter)
26.48M29.61M29.61M29.61M31.49M37.16M37.16M37.16M37.16M37.16M37.16M37.16M37.16M37.16M37.16M37.16M37.16M37.16M37.16M
EBITDA (Quarter)
-18.52M-14.81M-14.27M-15.41M-17.27M-14.01M-18.02M-8.74M-9.56M-10.23M-11.25M-12.53M-10.62M-11.73M-13.65M-20.26M-18.04M-20.27M-20.37M
Interest Expenses (Quarter)
2.05M5.50M0.67M0.05M0.45M0.89M1.35M0.45M0.91M1.38M1.10M0.47M0.94M1.43M1.94M0.53M1.90M9.59M121.25M
Tax Rate (Quarter)